Robert G. L. Shorr
Fondatore presso Cornerstone Pharmaceuticals, Inc.
Posizioni attive di Robert G. L. Shorr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | - | - | |
| Amministratore Delegato | 01/01/2000 | 10/10/2014 | |
| Stony Brook University | Corporate Officer/Principal | 01/01/1998 | - |
| Tissue Engineering Charities, Inc. | Direttore/Membro del Consiglio | 16/05/2011 | - |
| Imperial College London | Direttore/Membro del Consiglio | 01/01/1999 | - |
Storia della carriera di Robert G. L. Shorr
Precedenti posizioni note di Robert G. L. Shorr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 31/03/2005 | 01/02/2018 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direttore/Membro del Consiglio | - | 28/04/2005 |
| UNITED THERAPEUTICS CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2005 | 01/01/2005 |
| Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01/01/1988 | 01/01/1988 |
| AT Biochem, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
| Fondatore | 07/05/2010 | - | |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Robert G. L. Shorr
| University of London | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Regno Unito | 4 |
Posizioni
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Aziende private | 5 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
| Smithkline & French Laboratories US, Inc. | |
| AT Biochem, Inc. | |
| Tissue Engineering Charities, Inc. |
- Borsa valori
- Insiders
- Robert G. L. Shorr
- Esperienza
